Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
Simone Di Franco, Barbara Parrino, Miriam Gaggianesi, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102664-102664
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation
Luorui Shang, Yichong Wang, Jinxiao Li, et al.
Journal of Ethnopharmacology (2022) Vol. 302, pp. 115876-115876
Open Access | Times Cited: 110
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 37
Oxadiazole: A highly versatile scaffold in drug discovery
Nisheeth C. Desai, Jahnvi D. Monapara, Aratiba M. Jethawa, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 35
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 32
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3679-3679
Open Access | Times Cited: 29
Update on Emerging Therapies for Advanced Colorectal Cancer
Olatunji B. Alese, Christina Wu, William J. Chapin, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 26
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 288-288
Open Access | Times Cited: 24
Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies
Doralyn S. Dalisay, Chuckcris P. Tenebro, Edna M. Sabido, et al.
Marine Drugs (2024) Vol. 22, Iss. 3, pp. 114-114
Open Access | Times Cited: 6
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone, Camilla Pecoraro, Giovanna Panzeca, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 412-412
Open Access | Times Cited: 19
Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation
Jacqueline Nathansen, Felix Meyer, Luise Müller, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4818-4818
Open Access | Times Cited: 33
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
Miriam Gaggianesi, Simone Di Franco, Vincenzo Davide Pantina, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 19-19
Open Access | Times Cited: 31
Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities
Yiyang Li, Zhizhong Xie, Xiaoyong Lei, et al.
Bioorganic Chemistry (2024), pp. 107160-107160
Closed Access | Times Cited: 3
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, et al.
Cell Reports (2021) Vol. 37, Iss. 9, pp. 110060-110060
Open Access | Times Cited: 24
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51
Alice Turdo, Miriam Gaggianesi, Simone Di Franco, et al.
Oncogene (2022) Vol. 41, Iss. 15, pp. 2196-2209
Open Access | Times Cited: 16
Acridine Based N-Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties
Mária Vilková, Monika Hudáčová, Nikola Palušeková, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2883-2883
Open Access | Times Cited: 16
Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives – An Update
Ramanjulu Abinaya, Santhanam Srinath, S. Soundarya, et al.
Journal of Molecular Structure (2022) Vol. 1261, pp. 132750-132750
Closed Access | Times Cited: 15
SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis
Xiaoming Liu, Yongqiang Zheng, Mengqing Xiao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 15
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 2
Substituted furan sulfonamides as carbonic anhydrase inhibitors: Synthesis, biological and in silico studies
Andrea Angeli, В. Г. Карцев, Anthi Petrou, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106621-106621
Closed Access | Times Cited: 7
Synthesis and Antimicrobial Activity of New Heteroaryl(aryl) Thiazole Derivatives Molecular Docking Studies
В. Г. Карцев, Athina Geronikaki, Alexander A. Zubenko, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1337-1337
Open Access | Times Cited: 12
Benzohydrazide as a good precursor for the synthesis of novel bioactive and anti-oxidant 2-phenyl-1,3,4-oxadiazol-aminoacid derivatives: Structural determination, biological and anti-oxidant activity
Khaled Briki, Talal Lahreche, Mouna Souad Abbassi, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 6, pp. 105767-105767
Open Access | Times Cited: 1
CELL CYCLE DYSREGULATION IN CANCER
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024), pp. 100030-100030
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top